Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney (Q37307966)
Jump to navigation
Jump to search
scientific article published on 03 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney |
scientific article published on 03 October 2016 |
Statements
1 reference
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney (English)
1 reference
Jeffrey Miner
1 reference
Philip K Tan
1 reference
David Hyndman
1 reference
Sha Liu
1 reference
Cory Iverson
1 reference
Payal Nanavati
1 reference
David T Hagerty
1 reference
Kimberly Manhard
1 reference
Zancong Shen
1 reference
Jean-Luc Girardet
1 reference
Li-Tain Yeh
1 reference
Robert Terkeltaub
1 reference
Barry Quart
1 reference
3 October 2016
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference